MedPath
FDA Approval

TRICITRATES

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 21, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Potassium citrate(550 mg in 5 mL)
VS-01(334 mg in 5 mL)
Sodium citrate(500 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

ATLANTIC BIOLOGICALS CORP.

ATLANTIC BIOLOGICALS CORP.

047437707

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TRICITRATES

Product Details

NDC Product Code
17856-0677
Route of Administration
ORAL
Effective Date
September 26, 2018
Code: EE90ONI6FFClass: ACTIBQuantity: 550 mg in 5 mL
VS-01Active
Code: 2968PHW8QPClass: ACTIMQuantity: 334 mg in 5 mL
Code: 1Q73Q2JULRClass: ACTIBQuantity: 500 mg in 5 mL
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
POLYETHYLENE GLYCOLSInactive
Code: 3WJQ0SDW1AClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

CONTRAINDICATIONS SECTION

CONTRAINDICATIONS

Severe renal impairment with oliguria or azotemia, untreated Addison's disease, or severe myocardial damage. In certain situations, when patients are on a sodium-restricted diet, the use of potassium citrate may be preferable; or, when patients are on a potassium-restricted diet, the use of sodium citrate may be preferable.


© Copyright 2025. All Rights Reserved by MedPath